Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2009

Open Access 01-12-2009 | Original Article

Routine Rapid HIV Screening in Six Community Health Centers Serving Populations at Risk

Authors: Janet J. Myers, PhD, MPH, Cheryl Modica, PhD, MPH, BSN, Mi-Suk Kang Dufour, PhD(cand), MPH, Caryn Bernstein, BS, Kathleen McNamara, RN

Published in: Journal of General Internal Medicine | Issue 12/2009

Login to get access

Abstract

Background

In 2006, to increase opportunities for patients to become aware of their HIV status, the Centers for Disease Control and Prevention released updated guidelines for routine, opt-out HIV screening of adults, adolescents, and pregnant women in healthcare settings. To date, there are few documented applications of these recommendations.

Objective

To measure the impact of application of the guidelines for routine screening in health centers serving communities disproportionately affected by HIV in the southeastern US.

Design

A multi-site program implementation study, describing patients tested and not tested and assessing changes in testing frequency before and after new guidelines were implemented.

Participants

All patients aged 13 to 64 seen in participating health centers.

Interventions

Routine rapid HIV screening in accord with CDC guidelines.

Measurements

The frequency of testing before and after routine screening was in place and demographic differences in offering and receipt of testing.

Main Results

Compared to approximately 3,000 patients in the year prior to implementation, 16,148 patients were offered testing with 10,769 tested. Of 39 rapid tests resulting in preliminary positives, 17 were newly detected infections. Among these patients, 12 of 14 receiving referrals were linked to HIV care. Nineteen were false positives. Younger patients, African Americans and Latinos were more likely to receive testing.

Conclusions

By integrating CDC-recommended guidelines and applying rapid test technology, health centers were able to provide new access to HIV testing. Variation across centers in offering and receiving tests may indicate that clinical training could enhance universal access.
Literature
1.
go back to reference Centers for Disease Control and Prevention Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Morbid Mortal Wkly Rep 2006;55(RR-14):1–17. Centers for Disease Control and Prevention Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Morbid Mortal Wkly Rep 2006;55(RR-14):1–17.
3.
go back to reference Weis K, Liese A, Hussey J, et al. A routine HIV screening program in a South Carolina community health center in an area of low HIV prevalence. AIDS Patient Care and STDs. 2009; 23: 251–258.CrossRefPubMed Weis K, Liese A, Hussey J, et al. A routine HIV screening program in a South Carolina community health center in an area of low HIV prevalence. AIDS Patient Care and STDs. 2009; 23: 251–258.CrossRefPubMed
6.
go back to reference Dieffenbach C, Fauci A. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009; 301: 2380–2382.CrossRefPubMed Dieffenbach C, Fauci A. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009; 301: 2380–2382.CrossRefPubMed
7.
go back to reference White DE, Warren O, Scribner AN, Frazee BW. Missed Opportunities for earlier HIV diagnosis in an emergency department despite an HIV screening program. AIDS Patient Care and STDs. 2009; 23: 245–250.CrossRefPubMed White DE, Warren O, Scribner AN, Frazee BW. Missed Opportunities for earlier HIV diagnosis in an emergency department despite an HIV screening program. AIDS Patient Care and STDs. 2009; 23: 245–250.CrossRefPubMed
8.
go back to reference Walensky RP, Losina E, Steger-Craven KA, Freedberg KA. Identifying undiagnosed human immunodeficiency virus: The yield of routine, voluntary inpatient testing. Arch Intern Med. 2002; 162: 887–892.CrossRefPubMed Walensky RP, Losina E, Steger-Craven KA, Freedberg KA. Identifying undiagnosed human immunodeficiency virus: The yield of routine, voluntary inpatient testing. Arch Intern Med. 2002; 162: 887–892.CrossRefPubMed
9.
go back to reference Walensky RP, Losina E, Malatesta L, et al. Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health. 2005; 95: 71–73.CrossRefPubMed Walensky RP, Losina E, Malatesta L, et al. Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health. 2005; 95: 71–73.CrossRefPubMed
10.
go back to reference Greenwald JL, Rich CA, Bessega S, Posner MA, Maeda JL, Skolnik PR. Evaluation of the Centers for Disease Control and Prevention’s recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: Who are we missing? Mayo Clin Proc. 2006; 81: 452–458.CrossRefPubMed Greenwald JL, Rich CA, Bessega S, Posner MA, Maeda JL, Skolnik PR. Evaluation of the Centers for Disease Control and Prevention’s recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: Who are we missing? Mayo Clin Proc. 2006; 81: 452–458.CrossRefPubMed
11.
go back to reference Routinely recommended HIV testing at an urban urgent care clinic—Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:538–541. Routinely recommended HIV testing at an urban urgent care clinic—Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:538–541.
12.
go back to reference Wesolowski LG, MacKellar DA, Facente SN, Dowling T, et al. Post-marketing Surveillance Team. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS. 2006; 20: 1667–1668.CrossRef Wesolowski LG, MacKellar DA, Facente SN, Dowling T, et al. Post-marketing Surveillance Team. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS. 2006; 20: 1667–1668.CrossRef
14.
go back to reference Gray R, Makumbi F, Serwadda D, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 2007; 335: 188–190.CrossRefPubMed Gray R, Makumbi F, Serwadda D, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 2007; 335: 188–190.CrossRefPubMed
Metadata
Title
Routine Rapid HIV Screening in Six Community Health Centers Serving Populations at Risk
Authors
Janet J. Myers, PhD, MPH
Cheryl Modica, PhD, MPH, BSN
Mi-Suk Kang Dufour, PhD(cand), MPH
Caryn Bernstein, BS
Kathleen McNamara, RN
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 12/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-1070-1

Other articles of this Issue 12/2009

Journal of General Internal Medicine 12/2009 Go to the issue

Thanks to Reviewers

Thanks to Reviewers

Letter to the Editor

Do New Drugs Save Lives?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.